Product Liability · Hernia Mesh
Hernia Mesh
Hernia mesh — product and complication review
Hernia mesh is a surgical patch used to reinforce weakened abdominal tissue. Certain polypropylene and coated mesh products have been tied to a pattern of failure — adhesion to bowel or organs, chronic pain, infection, mesh migration, and revision surgery. Claims have involved multiple products and court proceedings; the relevant product and case history matter.
Background
What this litigation is about.
Hernia mesh implants are supposed to strengthen the abdominal wall during and after hernia repair. In practice, plaintiffs allege that certain products were sold without adequate warning about how the polypropylene and coatings degrade in the body, shrink, adhere to bowel or organs, or trigger chronic inflammation.
The largest hernia mesh MDL centers on Davol/C.R. Bard polypropylene devices — including the Ventralight ST, 3DMax, Perfix Plug, and PerFix — pending in the Southern District of Ohio before Judge Sargus. Bellwether trials have produced a mix of outcomes: notably a $255,000 plaintiff verdict in Milanesi v. C.R. Bard (2022) and further jury verdicts in subsequent bellwethers.
Ethicon Physiomesh, Atrium C-QUR and Covidien products have been involved in separate proceedings. Do not assume that a past settlement or trial establishes present claim availability.
Reported injuries
Reported concerns and potential losses.
Adhesion & bowel obstruction
Mesh adheres to intestine or organs, sometimes causing blockage.
Chronic pain
Ongoing groin, abdominal, or pelvic pain that persists long after surgery.
Infection
Mesh becomes a chronic source of infection requiring removal.
Mesh migration or contraction
The patch shifts or shrinks, distorting anatomy and causing new hernias.
Fistula formation
Abnormal connections between organs — a serious complication of certain mesh.
Revision surgery
Additional operations to remove failed mesh — often difficult and incomplete.
Individual review
Facts that may be relevant.
You had a hernia repair with a mesh implant (Bard, Ethicon Physiomesh, Atrium C-QUR, Covidien, or similar).
You developed adhesion, obstruction, chronic pain, infection, or a fistula tied to the mesh.
You underwent — or your surgeon has recommended — revision surgery to remove or repair the mesh.
You can identify the surgical date and, ideally, the mesh product used (operative records usually list it).
Document care even without revision surgery
Not everyone with persistent symptoms undergoes another operation. A clinician’s explanation of conservative treatment or why surgery is unsuitable can be important context; symptoms alone do not establish mesh failure.
- Keep the original repair report and implant identifiers separate from later revision records.
- Save imaging, specialist assessments, and recommendations for or against further surgery.
- Note recurrent hernias, treatment attempts, and specific limits on lifting, work, or daily activities.
Key events
A timeline of what has happened so far.
2000s
Widespread adoption of polypropylene and coated hernia mesh products in U.S. hospitals.
2016
Ethicon withdraws Physiomesh from the global market after post-market data shows elevated revision rates.
2018
JPML consolidates Bard/Davol polypropylene hernia mesh cases as MDL 2846 in the Southern District of Ohio.
2020–2023
Bellwether trials in MDL 2846 begin; verdicts include plaintiff wins (Milanesi ~$255K) and defense wins.
Frequently asked
Questions answered plainly.
This page is for general information only, is not legal advice, and does not create an attorney-client relationship. Case statuses, MDL orders, and settlement terms change; call our office for a current review of your specific situation.
Free · Confidential · No obligation
Not sure whether you have a case? Start with a conversation.
Tell us what happened, at your pace. We will listen, answer honestly, and — if we can help — begin quietly, right away.